2018
DOI: 10.1002/cmdc.201800304
|View full text |Cite
|
Sign up to set email alerts
|

Deciphering Specificity Determinants for FR900359‐Derived Gqα Inhibitors Based on Computational and Structure–Activity Studies

Abstract: Direct targeting of intracellular Gα subunits of G protein-coupled receptors by chemical tools is a challenging task in current pharmacological studies and in the development of novel therapeutic approaches. In this study we analyzed novel FR900359-based analogs from natural sources, synthetic cyclic peptides, as well as all so-far known G α inhibitors in a comprehensive study to devise a strategy for the elucidation of characteristics that determine interactions with and inhibition of G in the specific FR/YM-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
72
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 31 publications
(74 citation statements)
references
References 44 publications
2
72
0
Order By: Relevance
“…The IP 1 and cAMP assays used to examine the biological activity of YM‐254890 and related analogs were also used to measure the inhibitory effects of FR900359 and related analogs on G q ‐mediated signaling, while the experimental setups were different in terms of cell number, cell incubation time, concentration of related agents, and the machine of detection. These different experimental set ups might account for the variation in potency of the same compounds as previously reported (Figure ) . Moreover, two semisynthetic analogs of FR900359 were also reported, which were obtained either by esterification of the β‐HyLeu‐1 hydroxyl group with hexanoic anhydride ( 52 , Figure ), or by Michael addition, applying 2‐aminoethanethiol to form the corresponding thioether at the double bond of N ‐MeDha ( 53 , Figure ).…”
Section: Selective Gq Inhibitorsmentioning
confidence: 80%
See 4 more Smart Citations
“…The IP 1 and cAMP assays used to examine the biological activity of YM‐254890 and related analogs were also used to measure the inhibitory effects of FR900359 and related analogs on G q ‐mediated signaling, while the experimental setups were different in terms of cell number, cell incubation time, concentration of related agents, and the machine of detection. These different experimental set ups might account for the variation in potency of the same compounds as previously reported (Figure ) . Moreover, two semisynthetic analogs of FR900359 were also reported, which were obtained either by esterification of the β‐HyLeu‐1 hydroxyl group with hexanoic anhydride ( 52 , Figure ), or by Michael addition, applying 2‐aminoethanethiol to form the corresponding thioether at the double bond of N ‐MeDha ( 53 , Figure ).…”
Section: Selective Gq Inhibitorsmentioning
confidence: 80%
“…b, Inhibition of the adenosine diphosphate (ADP)‐induced platelet aggregation in human platelet‐rich plasma . c, d, and e, Inhibition of carbachol‐induced inositol monophosphate (IP 1 ) production in Chinese hamster ovary (CHO) cells that stably express the M 1 muscarinic receptor in different papers: (c) from Xiong et al, (d) from Zhang et al and Xiong et al, and (e) from Reher et al Equipotent analogs are highlighted (pink). The chemical structures were determined by mass spectrometry, one‐ and two‐dimensional nuclear magnetic resonance (NMR) spectrum analysis, chiral high‐performance liquid chromatography (HPLC), Marfey's analysis, high‐resolution mass spectroscopy (HRMS), infrared spectroscopy (IR), and optical rotation.…”
Section: Selective Gq Inhibitorsmentioning
confidence: 99%
See 3 more Smart Citations